Preventive Care

  • Laboratory testing for respiratory viruses for the clinician CME article
    Christopher C. Attaway, MD, MSc and Hannah Wang, MD, D(ABMM)
    Cleveland Clinic Journal of Medicine September 2024, 91 (9 suppl 1) S42-S49; DOI: https://doi.org/10.3949/ccjm.91.s1.07
  • Meeting the challenge of vaccine hesitancy CME article
    Oluwatosin Goje, MD, MSCR, FACOG and Aanchal Kapoor, MD, MEd
    Cleveland Clinic Journal of Medicine September 2024, 91 (9 suppl 1) S50-S56; DOI: https://doi.org/10.3949/ccjm.91.s1.08
  • 2023 Update in ambulatory general internal medicine
    Ashley Lim
    Cleveland Clinic Journal of Medicine March 2024, 91 (3) 145-146; DOI: https://doi.org/10.3949/ccjm.91c.03001
  • In Reply: 2023 Update in ambulatory general internal medicine
    Jason T. Alexander, MD, Simran K. Singh, MD, Sachin D. Shah, MD, Brianna Lambert, MD and Jeremy P. Smith, MD
    Cleveland Clinic Journal of Medicine March 2024, 91 (3) 146; DOI: https://doi.org/10.3949/ccjm.91c.03002
  • It’s a new year, looking back and looking forward
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine January 2024, 91 (1) 15-16; DOI: https://doi.org/10.3949/ccjm.91b.01024

    Reflections on highlights from 2023 and impending changes in 2024, along with some acknowledgments and farewells.

  • Gastric intestinal metaplasia and gastric cancer prevention: Watchful waiting
    Shrouq Khazaaleh, MD, Mohammad Alomari, MD, Mamoon Ur Rashid, MD, Daniel Castaneda, MD and Fernando J. Castro, MD
    Cleveland Clinic Journal of Medicine January 2024, 91 (1) 33-39; DOI: https://doi.org/10.3949/ccjm.91a.23015

    Malignancy develops in only a small minority of patients with gastric intestinal metaplasia. Recognition of clinical, endoscopic, and histologic features linked with cancer development is critical to identifying patients who require endoscopic surveillance.

  • 2023 Update in ambulatory general internal medicine
    Jason T. Alexander, MD, Simran K. Singh, MD, Sachin D. Shah, MD, Brianna Lambert, MD and Jeremy P. Smith, MD
    Cleveland Clinic Journal of Medicine January 2024, 91 (1) 40-46; DOI: https://doi.org/10.3949/ccjm.91a.23056

    Topics reviewed include prevention of chronic kidney disease progression, diet for preventing secondary cardiovascular disease, prevention of kidney-stone recurrence, drug therapy for weight loss, and cholesterol management.

  • Nonstatin therapy to reduce low-density lipoprotein cholesterol and improve cardiovascular outcomes
    Abhayjit Singh, MD and Leslie S. Cho, MD
    Cleveland Clinic Journal of Medicine January 2024, 91 (1) 53-63; DOI: https://doi.org/10.3949/ccjm.91a.23058

    Several new nonstatin medications have been approved in recent years, with robust data from clinical trials supporting their use in atherosclerotic disease.

  • To prophylax or not to prophylax for endocarditis: Still a question
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine August 2023, 90 (8) 455-456; DOI: https://doi.org/10.3949/ccjm.90b.08023

    Give prophylactic antibiotics before invasive dental procedures? On the surface, it may seem sensible. But we have more to learn about the successful clearance of bacteria from the bloodstream and why protective mechanisms occasionally fail.

  • Getting to the root of the problem: Should my patient receive antibiotics before dental procedures to prevent infective endocarditis?
    Cindy McCartney, MD, Thomas Crilley, MD and Steven Gordon, MD
    Cleveland Clinic Journal of Medicine August 2023, 90 (8) 465-467; DOI: https://doi.org/10.3949/ccjm.90a.22091

    Individual risk depends on inherent patient and procedural risk factors. The authors offer practical points to aid decision-making.

Pages